Raphael A. Nemenoff
Affiliations: | Pharmacology | University of Colorado Anschutz Medical Campus, Denver, Aurora, CO |
Area:
Pharmacology, Molecular Biology, Physiology Biology, PathologyGoogle:
"Raphael Nemenoff"Children
Sign in to add trainee| Stacy A. Blaine | grad student | 2004 | University of Colorado, Denver |
| Allison C. Ostriker | grad student | 2014 | University of Colorado, Denver |
Collaborators
Sign in to add collaborator| Lynn E. Heasley | collaborator | 1991-2019 | University of Colorado, Denver |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Schubert L, Le AT, Hinz TK, et al. (2023) A Functional sgRNA-CRISPR screening method for generating murine RET and NTRK1 rearranged oncogenes. Biology Open |
| Schubert L, Le AT, Hinz TK, et al. (2023) A Rapid, Functional sgRNA Screening Method for Generating Murine RET and NTRK1 Fusion Oncogenes. Biorxiv : the Preprint Server For Biology |
| Sisler DJ, Hinz TK, Le AT, et al. (2023) Evaluation of KRAS inhibitor responses in novel murine KRAS lung cancer cell line models. Frontiers in Oncology. 13: 1094123 |
| Kleczko EK, Hinz TK, Nguyen TT, et al. (2023) Durable responses to alectinib in murine models of EML4-ALK lung cancer requires adaptive immunity. Npj Precision Oncology. 7: 15 |
| Kleczko EK, Poczobutt JM, Navarro AC, et al. (2023) Upregulation of complement proteins in lung cancer cells mediates tumor progression. Frontiers in Oncology. 12: 1045690 |
| Kleczko EK, Le AT, Hinz TK, et al. (2023) Novel EGFR-mutant mouse models of lung adenocarcinoma reveal adaptive immunity requirement for durable osimertinib response. Cancer Letters. 216062 |
| Johnson AM, Boland JM, Wrobel J, et al. (2021) Cancer cell-specific MHCII expression as a determinant of the immune infiltrate organization and function in the non-small cell lung cancer tumor microenvironment. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer |
| Gurule NJ, McCoach CE, Hinz TK, et al. (2021) A tyrosine kinase inhibitor-induced interferon response positively associates with clinical response in EGFR-mutant lung cancer. Npj Precision Oncology. 5: 41 |
| Korpela SP, Hinz TK, Oweida A, et al. (2021) Role of epidermal growth factor receptor inhibitor-induced interferon pathway signaling in the head and neck squamous cell carcinoma therapeutic response. Journal of Translational Medicine. 19: 43 |
| Nemenoff R. (2021) Activation of PPARγ in myeloid cells promotes lung cancer progression and metastasis. Oncoimmunology. 1: 403-404 |